Titan Biotech

Market Cap: Micro Cap
Industry: Chemicals
ISIN: INE150C01011
NSEID:
BSEID: 524717

INR

504.95

14.95 (3.05%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.61 k

{
  "main_header": {
    "sid": 779371,
    "name": "Titan Biotech",
    "stock_name": "Titan Biotech",
    "full_name": "Titan Biotech Ltd",
    "name_url": "stocks-analysis/titan-biotech",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "504.95",
    "chg": 14.95,
    "chgp": "3.05%",
    "dir": 1,
    "prev_price": "490.00",
    "mcapval": "417.28 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524717,
    "symbol": "",
    "ind_name": "Chemicals",
    "ind_code": 11,
    "isin": "INE150C01011",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "00:19 AM",
    "bse_nse_vol": "4.61 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/titan-biotech-779371-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Titan Biotech Faces Significant Volatility Amid Declining Profitability and Market Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-hits-52-week-low-amid-declining-stock-performance-and-financial-challenges-1626409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/TitanBiotech_priceRelatedfactors_821355.png",
        "date": "2025-03-27 13:08:00",
        "description": "Titan Biotech has faced notable volatility, reaching a 52-week low and experiencing a consecutive decline over three days. The company reported a significant drop in net profit and sales, alongside disappointing long-term operating profit growth. Despite a strong return on equity, it has underperformed the broader market."
      },
      {
        "title": "Titan Biotech Shows Short-Term Gains Amid Long-Term Underperformance in Chemicals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-reports-20-98-decline-over-past-year-amid-market-challenges-1173046",
        "imagepath": "",
        "date": "2025-03-03 10:28:33",
        "description": "Titan Biotech, a microcap company in the chemicals industry, has shown notable activity in the stock market today, with a daily performance increase of 0.78%. This contrasts with the broader market, as the Sensex experienced a decline of 0.37%. Over the past week, Titan Biotech's stock has risen by 2.36%, while the Sensex fell by 2.05%. \n\nDespite these short-term gains, Titan Biotech's one-year performance remains negative at -20.98%, significantly underperforming the Sensex, which has declined by only 1.19% during the same period. Year-to-date, the stock has dropped by 39.34%, compared to the Sensex's decline of 6.67%. \n\nIn terms of valuation, Titan Biotech has a price-to-earnings (P/E) ratio of 16.20, which is notably lower than the industry average of 41.43. Over the longer term, the company has demonstrated substantial growth, with a remarkable 655.87% increase over the past five years, outpacing the Se..."
      },
      {
        "title": "Titan Biotech Faces Market Pressures Amid Significant Stock Volatility and Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-hits-new-52-week-low-amid-ongoing-stock-decline-1045278",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TitanBiotech_priceRelatedfactors_459358.png",
        "date": "2025-02-18 14:05:24",
        "description": "Titan Biotech has faced notable volatility, hitting a new 52-week low while underperforming its sector. The stock has declined 27.27% over the past year, contrasting with the Sensex's gains. It is currently trading below multiple moving averages, reflecting ongoing challenges in its market position."
      },
      {
        "title": "Titan Biotech Hits 52-Week Low Amid Broader Market Gains and Sector Resilience",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-hits-52-week-low-at-rs-430-amid-27-27-annual-decline-1040050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TitanBiotech_priceRelatedfactors_451032.png",
        "date": "2025-02-17 09:40:19",
        "description": "Titan Biotech has reached a new 52-week low, reflecting a significant decline over the past year compared to the broader market. Despite this, the company has shown some resilience today, slightly outperforming its sector. The stock continues to trade below key moving averages, indicating ongoing challenges."
      },
      {
        "title": "Titan Biotech Faces Significant Volatility Amid Broader Market Challenges in October 2023",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/titan-biotech-hits-52-week-low-amid-sustained-decline-and-underperformance-1008647",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TitanBiotech_priceRelatedfactors_440040.png",
        "date": "2025-02-14 09:36:41",
        "description": "Titan Biotech has faced significant volatility, underperforming in the chemicals sector. The stock has seen a notable decline over the past two days and is trading below key moving averages. Its performance over the past year has also been disappointing compared to broader market trends."
      },
      {
        "title": "Titan Biotech Reports December 2024 Results Highlighting Liquidity Gains Amid Operational Challenges",
        "link": "https://www.marketsmojo.com/news/result-analysis/titan-biotech-reports-decline-in-financial-performance-for-december-2024-994858",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/TitanBiotech_quaterlyResult_423058.png",
        "date": "2025-02-12 18:51:18",
        "description": "Titan Biotech has announced its financial results for the quarter ending December 2024, revealing challenges in key metrics such as profit before tax and net sales, which reached their lowest in five quarters. However, the company reported its highest cash and cash equivalents in recent periods, indicating improved short-term liquidity."
      }
    ],
    "total": 70,
    "sid": "779371",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/titan-biotech-779371"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "05-Apr-2025",
      "details": "Compliance Certificate u/r 74(5) of SEBI(DP) Reg. 2018 for March 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2025",
      "details": "Closure of Trading Window",
      "source": "BSE"
    },
    {
      "caption": "Appointment Of Secretarial Auditor For The Financial Year Ended On 31/03/2025",
      "datetime": "24-Mar-2025",
      "details": "Appointment of Secretarial Auditor for the financial year ended on 31/03/2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Titan Biotech Ltd has declared <strong>20%</strong> dividend, ex-date: 23 Sep 24",
          "dt": "2024-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Titan Biotech Faces Significant Volatility Amid Declining Profitability and Market Underperformance

2025-03-27 13:08:00

Titan Biotech has faced notable volatility, reaching a 52-week low and experiencing a consecutive decline over three days. The company reported a significant drop in net profit and sales, alongside disappointing long-term operating profit growth. Despite a strong return on equity, it has underperformed the broader market.

Titan Biotech Shows Short-Term Gains Amid Long-Term Underperformance in Chemicals Sector

2025-03-03 10:28:33

Titan Biotech, a microcap company in the chemicals industry, has shown notable activity in the stock market today, with a daily performance increase of 0.78%. This contrasts with the broader market, as the Sensex experienced a decline of 0.37%. Over the past week, Titan Biotech's stock has risen by 2.36%, while the Sensex fell by 2.05%. Despite these short-term gains, Titan Biotech's one-year performance remains negative at -20.98%, significantly underperforming the Sensex, which has declined by only 1.19% during the same period. Year-to-date, the stock has dropped by 39.34%, compared to the Sensex's decline of 6.67%. In terms of valuation, Titan Biotech has a price-to-earnings (P/E) ratio of 16.20, which is notably lower than the industry average of 41.43. Over the longer term, the company has demonstrated substantial growth, with a remarkable 655.87% increase over the past five years, outpacing the Se...

Titan Biotech Faces Market Pressures Amid Significant Stock Volatility and Decline

2025-02-18 14:05:24

Titan Biotech has faced notable volatility, hitting a new 52-week low while underperforming its sector. The stock has declined 27.27% over the past year, contrasting with the Sensex's gains. It is currently trading below multiple moving averages, reflecting ongoing challenges in its market position.

Titan Biotech Hits 52-Week Low Amid Broader Market Gains and Sector Resilience

2025-02-17 09:40:19

Titan Biotech has reached a new 52-week low, reflecting a significant decline over the past year compared to the broader market. Despite this, the company has shown some resilience today, slightly outperforming its sector. The stock continues to trade below key moving averages, indicating ongoing challenges.

Titan Biotech Faces Significant Volatility Amid Broader Market Challenges in October 2023

2025-02-14 09:36:41

Titan Biotech has faced significant volatility, underperforming in the chemicals sector. The stock has seen a notable decline over the past two days and is trading below key moving averages. Its performance over the past year has also been disappointing compared to broader market trends.

Titan Biotech Reports December 2024 Results Highlighting Liquidity Gains Amid Operational Challenges

2025-02-12 18:51:18

Titan Biotech has announced its financial results for the quarter ending December 2024, revealing challenges in key metrics such as profit before tax and net sales, which reached their lowest in five quarters. However, the company reported its highest cash and cash equivalents in recent periods, indicating improved short-term liquidity.